Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UrtesteWAR:URT +8.35%33 Buyback Yield % is 0.00 as of Jul. 30, 2026. GuruFocus rates WAR:URT with a GF Score™ of 33/100 and a GF Value™ of zł284.55 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 735 Biotechnology companies, Urteste ranks worse than 136054.29% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Urteste's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:URT vs VRTX, REGN, RVMD: Buyback Yield % Comparison
For the Biotechnology subindustry, Urteste's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Urteste Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Urteste's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Urteste's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Urteste (WAR:URT) has a Buyback Yield % of 0.00 as of Jul. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Urteste and its competitors. According to the industry distribution chart, Urteste ranks #999999 out of 735 companies in the Biotechnology industry.
Is Urteste's Buyback Yield % too high?
Urteste's current Buyback Yield % is 0.00. Based on the distribution chart, Urteste ranks #999999 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Urteste has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Urteste's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Urteste ranks #999999 out of 735 companies for Buyback Yield %. This places Urteste in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Urteste and its competitors. Urteste's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Urteste stock overvalued right now?
Based on GuruFocus' analysis, Urteste (WAR:URT) is currently considered Possible Value Trap. The stock's GF Value™ is zł284.55, compared to a current price of zł46.70 — trading 83.6% below its estimated fair value. The current Buyback Yield % is 0.00. Urteste's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Urteste (WAR:URT), the current Buyback Yield % is 0.00 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Urteste (WAR:URT) Overvalued in 2026?
Based on GuruFocus' analysis, Urteste stock appears to be undervalued.
The current stock price of zł46.70 is trading 83.6% below its estimated GF Value™ of zł284.55.
GuruFocus considers Urteste to be Possible Value Trap.
Key valuation signals for WAR:URT:
Buyback Yield %: 0.00
GF Value™: zł284.55 vs. price of zł46.70 (83.6% below fair value)
No single metric tells the full story. See the WAR:URT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Urteste SA specialises in the development of technology allowing the detection of cancers at the early stages of their development. The companies technology helps detect cancers by measuring the activity of the enzymes in urine. Urteste develops diagnostic tests for more than ten common cancers.
33GF Score
Get the complete analysis for WAR:URT
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:URT has been successfully added to your 
